title: Emerging innovations in clinical trial design.
abstract: Designs of clinical trials have changed little since the advent of randomization in the 1940s. Modern innovations in designs are being driven by the increasing recognition in clinical research that diseases are heterogeneous and patients who apparently have the same disease require different therapies. This article describes some innovations in clinical trial design across therapeutic areas but with a focus on oncology. No one knows what the future holds for clinical trial design but the status quo of large trials that pretend the patient population is homogeneous is not sustainable, either economically or scientifically/medically. No one knows what the eventual business model and regulatory model will be, but they will be very different from today's.
authors.affiliation: University of Texas, MD Anderson Cancer Center, Biostatistics, Houston, Texas, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Berry
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D008495:Medical Oncology / Q000379:methods*; D012107:Research Design